In the US, Hydroxychloroquine (hydroxychloroquine systemic) is a member of the following drug classes: antimalarial quinolines, antirheumatics and is used to treat Dermatomyositis, Malaria, Malaria Prevention, Rheumatoid Arthritis, Sjogren's Syndrome, Systemic Lupus Erythematosus and Undifferentiated Connective Tissue Disease.
US matches:
- Hydroxychloroquine
- Hydroxychloroquine Sulfate
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
P01BA02
CAS registry number (Chemical Abstracts Service)
0000118-42-3
Chemical Formula
C18-H26-Cl-N3-O
Molecular Weight
335
Therapeutic Categories
Disease-modifying antirheumatic drug, DMARD
Antiprotozoal agent: Antimalarial
Chemical Name
Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-
Foreign Names
- Hydroxychloroquinum (Latin)
- Hydroxychloroquin (German)
- Hydroxychloroquine (French)
- Hidroxicloroquina (Spanish)
Generic Names
- Hydroxychloroquine (OS: BAN)
- Idroxiclorochina (OS: DCIT)
- Oxychloroquine (IS)
- Win 1258-2 (IS)
- Hydroxychloroquine Sulphate (OS: BANM)
- Hydroxychloroquine Sulfate (PH: USP 32)
- Hydroxychloroquine Sulphate (PH: BP 2010)
Brand Names
- HCQS
Medigroup, Peru - Planil
Medicon, Bangladesh - Plaquenil
Sanofi Aventis, Tunisia - Polirreumin
TRB, Argentina - Apo-Hydroxyquine
Apotex, Canada - Axokine
Rontag, Argentina - Dimard
Metlen, Colombia - Dolquine
Inmunosyn, Colombia; Rubio, Spain - Ercoquin
Medic, Denmark - Evoquin
Ivax, Argentina - Gen-Hydroxychloroquine
Genpharm, Canada - Geniquin
Genovate, Taiwan - Hydroxychloroquine Sulfate
Ipca, United States; Mylan, United States; Sandoz, United States; Teva USA, United States; Watson, United States; West-Ward, United States; Zydus, United States - Metirel
Pfizer, Argentina - Narbon
Buxton, Argentina - Oxiklorin
Orion, Finland - Plaquenil
Delphi, Netherlands; Sanofi-Aventis, Argentina; Sanofi-Aventis, Australia; Sanofi-Aventis, Belgium; Sanofi-Aventis, Canada; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Denmark; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Georgia; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Ireland; Sanofi-Aventis, Israel; Sanofi-Aventis, Italy; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Malta; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Norway; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States; Sanofi-Synthelabo, Ghana; Sanofi-Synthelabo, Iceland; Sanofi-Synthelabo, Kenya; Sanofi-Synthelabo, Luxembourg; Sanofi-Synthelabo, Nigeria; Sanofi-Synthelabo, Romania; Sanofi-Synthelabo, Tanzania; Sanofi-Synthelabo, Uganda; Winthrop, Slovakia - Plaquinol
Biosaúde, Portugal; Sanofi-Aventis, Chile; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Venezuela; Sanofi-Synthelabo, Peru - Quensyl
Sanofi-Aventis, Germany - Reconil
Incepta, Bangladesh - Reuquinol
Apsen, Brazil
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
